McGrath Lynne Fahey 4
4 · Alzamend Neuro, Inc. · Filed Jul 16, 2021
Insider Transaction Report
Form 4
McGrath Lynne Fahey
Director
Transactions
- Award
Stock Options (Right to Buy)
2021-06-15+300,000→ 300,000 totalExercise: $2.50Exp: 2026-09-12→ Common Stock (300,000 underlying) - Award
Restricted Stock Grant
2021-06-15+100,000→ 100,000 totalExp: 2024-09-13→ Common Stock (100,000 underlying)
Footnotes (3)
- [F1]Each restricted stock unit is the economic equivalent of one share of Common Stock, par value $0.0001, of Alzamend Neuro, Inc.
- [F2]The restricted stock grant vest contemporaneously with the Options (as defined below).
- [F3]The stock options (the "Options") vest in 36 equal monthly installments commencing on September 13, 2021 and are exercisable upon vesting.